CL
MYGN icon

CIM LLC’s Myriad Genetics MYGN Stock Holding History

CIM LLC’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,405
Closed -$349K – 91
2016
Q2 		$349K Hold
11,405
– – 0.17% 57
2016
Q1 		$427K Buy
+11,405
New +$430K 0.21% 49
2015
Q1 		– Sell
-12,635
Closed -$430K – 85
2014
Q4 		$430K Sell
12,635
-2,505
-17% -$88.9K 0.2% 50
2014
Q3 		$584K Buy
15,140
+125
+0.8% +$4.66K 0.29% 29
2014
Q2 		$584K Buy
15,015
+2,900
+24% +$108K 0.29% 28
2014
Q1 		$414K Buy
+12,115
New +$375K 0.22% 38

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CIM LLC's MYGN Position: Q3 2016 in Review

CIM LLC sold out of Myriad Genetics (MYGN) in Q3 2016, closing a stake of 11,405 shares — an estimated $349K sold.

CIM LLC first reported a position in MYGN in Q1 2014 and held it in 6 quarters. The position peaked at $584K in Q3 2014. 223 funds tracked by Wall St. Rank hold MYGN as of Q3 2016.

  • CIM LLC reported no remaining Myriad Genetics position as of Q3 2016 after selling out during the quarter.
  • CIM LLC sold 11,405 Myriad Genetics shares in Q3 2016, an estimated $349K.
  • CIM LLC first reported a position in Myriad Genetics in Q1 2014 and held it in 6 quarters.
  • CIM LLC's Myriad Genetics position peaked at $584K in Q3 2014.
  • 223 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2016.

Based on CIM LLC's 13F filing for Q3 2016, filed 17 Oct 2016.